Literature DB >> 998615

A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction.

J M Lusher, H Haghighat, A S Khalifa.   

Abstract

CNS infarction is a devastating complication in sickle cell anemia. Episodes are frequently repetitive and often result in permanent neurologic abnormalities. In an attempt to prevent such recurrences a periodic transfusion program was begun at the Children's Hospital of Michigan in 1969. Twenty-one children currently on the program receive buffy-coat poor transfusions on an out-patient basis every 3 weeks. Of 15 who have been on the program for periods of from 9 months to 5 3/4 years, none have had progression of neurologic abnormalities, and several have had definite improvement in neurologic function. One child who was not brought in regularly had recurrent CNS infarction. The only recognized complication has been one instance of serum hepatitis. While such a transfusion program is not without risk, it seems an effective way of preventing progression of neurologic abnormalities resulting from recurrent CNS infarction in sickle cell anemia.

Entities:  

Mesh:

Year:  1976        PMID: 998615     DOI: 10.1002/ajh.2830010210

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II.

Authors:  Miguel R Abboud; Eunsil Yim; Khaled M Musallam; Robert J Adams
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

Review 2.  Stroke in children with sickle cell anaemia: aetiology and treatment.

Authors:  C H Pegelow
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Steady state hemoglobin concentration and packed cell volume in homozygous sickle cell disease patients in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Adedoyin Dosunmu; Adewumi Adediran; Olajumoke Oshinaike; Adebola Phillip; Osunkalu Vincent; Arogundade Olanrewaju; Adelekan Oluwaseun
Journal:  Caspian J Intern Med       Date:  2012

Review 4.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

5.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

6.  Current management of sickle cell anemia.

Authors:  Patrick T McGann; Alecia C Nero; Russell E Ware
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

7.  Intracranial magnetic resonance angiography.

Authors:  P M Ruggieri; T J Masaryk; J S Ross; M T Modic
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Jan-Feb       Impact factor: 2.740

8.  Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion.

Authors:  Jon A Detterich; Suvimol Sangkatumvong; Roberta Kato; Ani Dongelyan; Adam Bush; Michael Khoo; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Transfusion       Date:  2012-11-26       Impact factor: 3.157

9.  Serum ferritin levels in adults with sickle cell disease in Lagos, Nigeria.

Authors:  Akinsegun A Akinbami; Adedoyin O Dosunmu; Adewumi A Adediran; Olajumoke O Oshinaike; Vincent O Osunkalu; Sarah O Ajibola; Olanrewaju M Arogundade
Journal:  J Blood Med       Date:  2013-05-22

10.  The association of CD81 polymorphisms with alloimmunization in sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Ryad Tamouza; Gama P Le Bouder; Ramita Dewan; Naomi L C Luban; Jacqueline Lasserre; Jacqueline Maury; François Lionnet; Rajagopal Krishnamoorthy; Robert Girot; Stanislav Vukmanovic
Journal:  Clin Dev Immunol       Date:  2013-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.